List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 76 studies with search of: "Interleukin-12"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
Condition: HIV Infections
Interventions: Drug: Interleukin-12;   Biological: HIV-1 C4-V3 Polyvalent Peptide Vaccine
2 Completed A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3
Condition: HIV Infections
Intervention: Drug: Interleukin-12
3 Terminated Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients
Conditions: HIV Infections;   Cryptosporidiosis
Intervention: Drug: IL-12
4 Completed Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
Condition: Lymphoma
Interventions: Biological: aldesleukin;   Biological: recombinant interleukin-12
5 Completed Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Condition: Sarcoma
Interventions: Biological: recombinant interleukin-12;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride
6 Completed A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine/Zidovudine;   Biological: Hepatitis A Vaccine (Inactivated);   Drug: Interleukin-12;   Drug: Nevirapine;   Drug: Stavudine;   Drug: Sargramostim
7 Completed Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections
Condition: Atypical Mycobacterium Infection
Intervention: Drug: Interleukin-12
8 Completed Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Conditions: Epidemic Kaposi's Sarcoma;   Recurrent Kaposi's Sarcoma
Intervention: Drug: interleukin-12
9 Completed Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection
Conditions: Acquired Immunodeficiency Syndrome;   Mycobacterium Avium-Intracellulare Infection
Intervention: Drug: Interleukin-12
10 Completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
Condition: Cancer
Interventions: Biological: recombinant interleukin-12;   Biological: trastuzumab
11 Completed Interleukin-12 in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Intervention: Biological: recombinant interleukin-12
12 Active, not recruiting Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Precancerous/Nonmalignant Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: recombinant interferon alfa;   Biological: recombinant interleukin-12
13 Completed Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Intervention: Biological: recombinant interleukin-12
14 Completed Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Intervention: Biological: recombinant interleukin-12
15 Completed Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Conditions: Breast Cancer;   Endometrial Cancer;   Gastric Cancer;   Lung Cancer;   Ovarian Cancer
Interventions: Biological: recombinant interleukin-12;   Biological: trastuzumab;   Drug: paclitaxel
16 Active, not recruiting Interleukin-12 in Treating Patients With Cancer in the Abdomen
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Malignant Mesothelioma;   Pancreatic Cancer;   Small Intestine Cancer
Intervention: Biological: recombinant interleukin-12
17 Completed Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: recombinant interleukin-12;   Biological: rituximab
18 Active, not recruiting Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: recombinant interferon alfa;   Biological: recombinant interleukin-12
19 Completed Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease
Condition: Lymphoma
Intervention: Biological: recombinant interleukin-12
20 Completed Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Biological: recombinant interleukin-12

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services